Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis

被引：0
|
作者：
Dijkmans, B.
Sridharan, S.
Fatenejad, S.
机构：
[1] Vrije Univ Amsterdam, Dept Rheumatol, Amsterdam, Netherlands
[2] Wyeth Ayerst Res, Res & Dev, Collegeville, MN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
    Miguel Senabre-Gallego, Jose
    Santos-Ramirez, Carlos
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Sanchez-Barrioluengo, Mabel
    Barber, Xavier
    Rosas, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 961 - 972
  • [2] Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
    Brandt, J
    Listing, J
    Haibel, H
    Sörensen, H
    Schwebig, A
    Rudwaleit, M
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2005, 44 (03) : 342 - 348
  • [3] LONG-TERM OUTCOME OF PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS WITH ETANERCEPT - SUSTAINED EFFICACY AND SAFETY AFTER 7 YEARS
    Baraliakos, X.
    Haibel, H.
    Fritz, C.
    Listing, J.
    Heldmann, F.
    Braun, J.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 638 - 638
  • [4] Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
    Baraliakos, Xenofon
    Haibel, Hildrun
    Fritz, Claudia
    Listing, Joachim
    Heldmann, Frank
    Braun, Juergen
    Sieper, Joachim
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (03)
  • [5] Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
    Xenofon Baraliakos
    Hildrun Haibel
    Claudia Fritz
    Joachim Listing
    Frank Heldmann
    Juergen Braun
    Joachim Sieper
    Arthritis Research & Therapy, 15
  • [6] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [7] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [8] Long term efficacy and safety of patients with ankylosing spondylitis treated with etanercept for years - Analysis of different types of response
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Song, I. H.
    Haibel, H.
    Heldmann, F.
    Brandt, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 745 - 746
  • [9] Long term efficacy and safety results and patient reported outcomes in patients with ankylosing spondylitis treated with etanercept for 4 years
    Dijkmans, B. A. C.
    Sieper, J.
    van der Linden, S.
    Martin-Mola, E.
    Leirisalo-Repo, M.
    Singh, A.
    Freundlich, B.
    Koenig, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 395 - 395
  • [10] Long term efficacy and safety of patients with Ankylosing spondylitis treated with etanercept for 5 years: Analysis of different types of response
    Baraliakos, Xenofon
    Listing, J.
    Fritz, C.
    Song, In-Ho
    Haibel, H.
    Heldmann, F.
    Rudwaleit, M.
    Sieper, J.
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S357 - S357
12345